In preeclampsia, excessive sFLT1 production and secretion from the placenta leads to elevated serum sFLT1, reducing free serum levels of VEGF and PlGF, inhibiting VEGF-mediated vasodilation and angiogenesis, causing hypertension and damaging vasculature [21]. Here, VEGFA is linked to preeclampsia.